MDT
Medtronic plc Healthcare - Medical Devices Investor Relations →
Medtronic plc (MDT) closed at $86.16 as of 2026-03-20, trading 5.3% above its 200-week moving average of $81.79. The stock is currently moving closer to the line, down from 6.5% last week. With a 14-week RSI of 29, MDT is in oversold territory.
Trading volume is running at 1.3x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.82 ratio) is neutral — neither side is clearly dominating.
Over the past 2711 weeks of data, MDT has crossed below its 200-week moving average 28 times. On average, these episodes lasted 25 weeks. Historically, investors who bought MDT at the start of these episodes saw an average one-year return of +17.2%.
With a market cap of $110.6 billion, MDT is a large-cap stock. The company generates a free cash flow yield of 3.7%. Return on equity stands at 9.4%. The stock trades at 2.3x book value.
MDT is a Dividend Aristocrat, having increased its dividend for 25 or more consecutive years. The current yield is 330.00%. Management has been repurchasing shares, with a 3.7% reduction over three years.
Over the past 33.2 years, a hypothetical investment of $100 in MDT would have grown to $2577, compared to $2683 for the S&P 500. MDT has returned 10.3% annualized vs 10.4% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -4.6% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: MDT vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After MDT Crosses Below the Line?
Across 21 historical episodes, buying MDT when it crossed below its 200-week moving average produced an average return of +8.5% after 12 months (median +6.0%), compared to +7.9% for the S&P 500 over the same periods. 67% of those episodes were profitable after one year. After 24 months, the average return was +31.2% vs +18.1% for the index.
Each line shows $100 invested at the moment MDT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
MDT has crossed below its 200-week MA 28 times with an average 1-year return of +17.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 1974 | May 1975 | 58 | 59.5% | -23.1% | +47509.3% |
| Jun 1975 | Jun 1975 | 4 | 6.0% | -27.1% | +55802.6% |
| Jul 1975 | Jul 1978 | 158 | 45.7% | -21.2% | +55444.0% |
| Oct 1978 | Oct 1978 | 1 | 0.3% | +82.0% | +77962.0% |
| Feb 1984 | Jul 1985 | 76 | 37.0% | -11.8% | +26770.0% |
| Aug 1985 | Aug 1985 | 3 | 8.2% | +148.4% | +29321.8% |
| Sep 1985 | Sep 1985 | 1 | 5.4% | +115.5% | +28588.9% |
| Apr 1993 | Apr 1993 | 1 | 7.4% | +36.6% | +4247.0% |
| Aug 1993 | Aug 1993 | 2 | 1.3% | +43.6% | +3732.1% |
| Sep 1993 | Sep 1993 | 1 | 0.0% | +59.0% | +3654.2% |
| Sep 2001 | Sep 2001 | 1 | 1.9% | +8.1% | +253.8% |
| May 2002 | May 2002 | 1 | 0.1% | +9.2% | +221.2% |
| Jun 2002 | Oct 2002 | 18 | 16.8% | +14.8% | +220.6% |
| Feb 2003 | Mar 2003 | 6 | 2.9% | +11.0% | +215.0% |
| Sep 2003 | Dec 2003 | 10 | 7.6% | +15.3% | +197.8% |
| May 2006 | May 2006 | 2 | 1.3% | +12.0% | +177.3% |
| Jun 2006 | Nov 2006 | 22 | 13.0% | +7.4% | +176.6% |
| Feb 2007 | Apr 2007 | 6 | 2.5% | +1.4% | +171.0% |
| Oct 2007 | Jun 2008 | 34 | 9.7% | -17.0% | +178.7% |
| Sep 2008 | Jan 2010 | 66 | 48.6% | -24.8% | +164.4% |
| Jan 2010 | Mar 2010 | 6 | 4.7% | -8.9% | +193.1% |
| May 2010 | Apr 2011 | 49 | 23.6% | +6.1% | +206.3% |
| May 2011 | Dec 2011 | 29 | 18.9% | -5.6% | +213.9% |
| Mar 2020 | Mar 2020 | 1 | 10.6% | +54.1% | +32.2% |
| Feb 2022 | Feb 2022 | 1 | 0.4% | -13.1% | -2.6% |
| May 2022 | Oct 2024 | 125 | 27.4% | -15.0% | -1.7% |
| Nov 2024 | Jan 2025 | 10 | 9.4% | +8.6% | +2.2% |
| Mar 2025 | Jun 2025 | 9 | 5.3% | N/A | +6.4% |
| Average | 25 | — | +17.2% | — |
Frequently Asked Questions
Is MDT below its 200-week moving average?
No. Medtronic plc (MDT) is currently 5.3% above its 200-week moving average of $81.79. It would need to fall to $81.79 to cross below the line.
What is MDT's 200-week moving average price?
Medtronic plc's 200-week moving average is $81.79 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when MDT drops below its 200-week moving average?
MDT has crossed below its 200-week moving average 28 times in our data. On average, buying at that moment produced a one-year return of +17.2%. These dips have historically been decent entry points. These episodes lasted 25 weeks on average.
Is MDT a good value right now?
Here's what our data says about MDT as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 29 (oversold). Free cash flow yield is 3.7%. Return on equity is 9.4%. Price-to-book is 2.3x. This is not a buy or sell recommendation — always do your own research.
How does MDT compare to the S&P 500?
Over the past 33.2 years, $100 invested in MDT would have grown to $2577, compared to $2683 for the S&P 500. That's 10.3% annualized vs 10.4% for the index. MDT has underperformed the broader market over this period.
Does MDT pay a dividend?
Yes. Medtronic plc currently pays a dividend yield of 330.00%. It is also a Dividend Aristocrat, meaning it has raised its dividend for 25 or more consecutive years.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20